TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Worst pain on the m-BPI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transfer to intensive care unit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 90-day costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rates of subsequent strokes
Endpoint domain: Adverse events/effects
Primary endpoint: time to 1-mm ST-segment depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: heart rate at peak exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Complete cure of onychomycosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of quitting smoking
Endpoint domain: Adverse events/effects
Primary endpoint: Change scores for the Sorensen test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: annual hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: number of medications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: health-care costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: micropush-out bond strength values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prescription of diuretics and calcium-channel blockers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increased cognitive dysfunction
Endpoint domain: Adverse events/effects
Primary endpoint: early shunt insufficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Convergent and divergent thinking performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: OPG concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Muscle Cross-Sectional Area (CSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Fat-Free Mass Index (FFMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Increased energy levels
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Enhanced mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Better sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Activation of the systemic immune response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Episodes of self-injury (SRI)
Endpoint domain: Adverse events/effects
Primary endpoint: Gleason grade detection (grade >= 7)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Gleason grade detection (grade >= 8)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Hypotension rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of all-cause complications
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of early termination of the procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Pain during drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean postoperative length of stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Postoperative peak creatine kinase‐myocardial band concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: pain associated with plantar keratomas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: function at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adverse reaction in the hyaluronic acid group
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy in classifying postures and transitions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Step counts during walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GST levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver function outcomes
Primary endpoint: Proportion of patients losing >15 letters from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients gaining vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression to legal blindness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean antibody response to poliovirus serotype 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean antibody response to poliovirus serotype 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cerebral vasodilator responsiveness (CVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: societal cost per quality-adjusted life year
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean wound healing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parental acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Isometric strength in each movement plane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activation of the paraspinal muscles during back extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean critical flicker fusion frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean light difference sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: asthma symptom frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: emergency visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: 6-month incidence of a second UTI
Endpoint domain: Mortality/survival
Primary endpoint: Cotinine-validated 7-day tobacco abstinence rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 50% improvement in depression scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower probability of major depression at follow up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported outcomes on sleep maintenance and onset
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events (somnolence)
Endpoint domain: Adverse events/effects
Primary endpoint: Imaging time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sufentanil consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mortality rates in patients with reactive pulmonary hypertension
Endpoint domain: Mortality/survival
Primary endpoint: Efficacy of treatment for tinnitus loudness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of serious side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Maximal percentage of increase in FEV1 at 30 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Evening PEFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of participants meeting criteria for PTSD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FEV1 response to inhaled corticosteroids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Constant-Murley scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Xerostomia Inventory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total dose of propofol used (mg/kg/min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to complete straight-line test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difficulty ranking of third molar extractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DAPT discontinuation
Endpoint domain: Physiological/clinical
Primary endpoint: pain-free range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: number of patients with painful arc during flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Baseline IUD position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IUD movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: orosensorial antinociceptive effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients consuming at least 75% of the prescribed ONS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean increased intake of ONS (35 ml or 84 kcal per day)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in right ventricular ejection fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Phase advance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved handwriting performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced cortical excitability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hamilton Anxiety Scale total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in severity of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: marked improvement in health state and general well-being
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: sensitivity of MR imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accuracy of MR imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area-under-curve value of MR imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative morphine consumption at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreased skin test IgE binding capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Statistical improvement in symptom and drug consumption scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and absence of side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Repeatability of OBF pneumotonometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement between OBF pneumotonometer and Goldmann tonometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of stroke
Endpoint domain: Mortality/survival
Primary endpoint: levels of IL-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: levels of IL-8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: incidence of BPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: LDL-C reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid parameters outcomes
Primary endpoint: HDL-C increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid parameters outcomes
Primary endpoint: Incidence of endothelial rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Efficacy of interventions for shoulder complaints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in n‐3/n‐6 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Increase in phagocytic activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Increase in neutrophil chemotactic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 24-h cumulative morphine requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain scores after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean arterial pressure (MAP) at 24 h after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to clinic return
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to ART initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regression of symptoms/signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of mood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak exercise systolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ratings of perceived exertion (Borg score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post‐ripening dilatation of 3 cm or more
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: deliveries by 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: requirement of augmentation with oxytocin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of chest tube drainage
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: post-operative swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiometabolic risk factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Awake at hospital discharge
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in clinical indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in P. aeruginosa counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Rate of response (pain and fullness)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total hospitalization cost
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Dyspnea with activities of daily living
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-efficacy for home walking
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Anxiety and distress associated with dyspnea
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ≥4-fold increase in neutralizing antibody titer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: infants' weight gain at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: readmission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin response to oral glucose loading
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: C-peptide response to oral glucose loading
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Erythrocyte membrane fatty acid concentrations (ALA, DHA, EPA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: breast milk HIV-1 RNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Driving abilities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Electroencephalogram (EEG) alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: reinfection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily charges for chemotherapy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Out-of-pocket costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Loss of income
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Changes in brain activation patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Smoking cessation experiences
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Food-allergy-specific quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: timed up and go scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: distance in the 6MWT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximal strength of the upper and lower limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: power output of the lower limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: %HRR values 180 days after allo‐HCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: %HRmax values 180 days after allo‐HCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: %VO2max values 180 days after allo‐HCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incremental QALYs
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of complete removal of stones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Accuracy in history taking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: moderate to vigorous physical activity (PA) percentage of time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Ksteep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in BSCVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weight gain during program end points
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Breslow thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of ulceration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of SLN metastasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: overall cure rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: BMI-z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful ovarian ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: No acute Grade 3 or 4 toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Oxygen uptake at maximal exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen uptake at lactate threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calls and texts per mile driven
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of asymptomatic bacteriuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Median difference in steps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cat keeping at 5 to 15 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adult cat acquisition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pet removal to reduce allergen
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Uterine contraction frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EROS scores
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: ATQ scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Injection pain units
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy intake after water immersion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Levels of Der p 1, Fel d 1 and Can f 1 allergens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Children's bedrooms with no detectable mite, cat or dog allergen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adverse events related to personal life
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse events related to occupational life
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse events related to suicidal thoughts
Endpoint domain: Adverse events/effects
Primary endpoint: Cardiovascular diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Consumption of a healthy diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Smoking habits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drinking habits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recommendation for publication
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Total abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Small-bowel transit time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes